🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the long-term safety of the study...
Status
Completed
Location
Nakayama Clinic
Start Date
2023-09-28
Trial ID
NCT06010004
Treatments Being Tested
The purpose of this study is to determine the effect of quinidine on the le...
Status
Completed
Location
ICON
Start Date
2024-12-06
Trial ID
NCT06704763
Treatments Being Tested
The main purpose of this study is to assess the effect of carbamazepine on ...
Status
Completed
Location
ICON Early Phase Services
Start Date
2024-05-06
Trial ID
NCT06370728
Treatments Being Tested
The purpose of this study is to measure cardiovascular outcomes with orforg...
Status
Recruiting
Location
Instituto de Investigaciones Clínicas Bahia Blanca
Start Date
2025-12-01
Trial ID
NCT07241390
Treatments Being Tested
The main purpose of this study is to see how orforglipron, compared with pl...
Status
Active Not Recruiting
Location
Clinical Research Institute of Arizona (CRI) - Sun City West
Start Date
2025-05-19
Trial ID
NCT06972472
Treatments Being Tested
The main purpose of this study is to investigate the efficacy and safety of...
Status
Completed
Location
Nishiyamadou Keiwa Hospital
Start Date
2023-07-31
Trial ID
NCT05931380
Treatments Being Tested
The main purpose of the study was to assess the effect of LY3502970 in part...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2021-09-29
Trial ID
NCT05051579
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Completed
Location
Qps-Mra, Llc
Start Date
2022-05-26
Trial ID
NCT05313802
Treatments Being Tested
The main purpose of this study is to evaluate how much LY3502970 gets into ...
Status
Completed
Location
LabCorp CRU, Inc.
Start Date
2023-04-26
Trial ID
NCT05841238
Treatments Being Tested